Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cytori receives FDA approval for fat transfer system
This fat transfer system is intended for use in the surgical specialties when the aspiration of soft tissue is desired, like plastic and reconstructive surgery, general surgery, neurosurgery,
This fat transfer system is intended for use in the surgical specialties when the aspiration of soft tissue is desired, like plastic and reconstructive surgery, general surgery, neurosurgery,
Insmed has decided to initiate the Phase III enabling trial based on promising results from an ongoing open-label, dose-escalation trial of Iplex in myotonic muscular dystrophy (MMD). To
BioTime believes that the development of products in the embryomics sector may allow Embryome Sciences to commercialize products more quickly, using less capital, than developing therapeutic products from
All of the shares of common stock were offered and sold by Discovery Labs pursuant to an effective registration statement previously filed with the Securities and Exchange Commission.
Groups treated with R788 at 100mg and 150mg orally, twice daily, showed higher ACR20, ACR50, ACR70 and DAS28 response rates than the placebo group. The efficacy results for
In 2007, Starlims expects to record a total of $1 million in revenue from this customer with the current $800,000 sale covering licenses for Starlims Version 10 software.
The results demonstrated that out of 13 acute myeloid leukemia (AML) patients treated in this study, three showed a complete response and one further AML patient became transfusion-independent;
GSK1160724 is a long-acting muscarinic antagonist (LAMA) discovered by Theravance through the application of multivalent drug design in a drug discovery program dedicated to finding new medicines for
Although VGX-410C was safe and well tolerated in patients in all three daily doses – 150, 300, and 600mg, one out of six patients in the 600mg dose
Accelrys says biological registration systems are inherently more complex than existing chemical registration systems which are commonplace in the pharmaceutical industry. In discussions with pharmaceutical companies, Accelrys has